Moreover, even though vascular dysfunction in AD has been usually ascribed to the accumulation of beta--amyloid and tau [11], a recent study suggests that neurovascular dysfunction associated with BBBi is an early biomarker of cognitive decline in AD regardless of beta-amyloid and tau abnormalities [12]. The gene discussed is MAPT; the disease is Alzheimer disease.